Cardiac amyloidosis medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Cardiac amyloidosis}} {{CMG}}; '''Associate Editor:''' {{CZ}} ==Supportive measures== *Physical activity may continue as long as the patient can tolerate it. *Diet restri...")
 
Line 3: Line 3:


==Supportive measures==
==Supportive measures==
*Physical activity may continue as long as the patient can tolerate it.  
Physical activity may continue as long as the patient can tolerate it.  


*Diet restrictions vary with the extent of [[cardiomyopathy]] and [[heart failure]]. These may include [[salt]] and/or [[fluid]] restrictions.
Diet restrictions vary with the extent of [[cardiomyopathy]] and [[heart failure]]. These may include [[salt]] and/or [[fluid]] restrictions.


==Pharmacotherapy==
==Pharmacotherapy==

Revision as of 15:30, 12 February 2012

Cardiac amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis medical therapy

CDC onCardiac amyloidosis medical therapy

Cardiac amyloidosis medical therapy in the news

Blogs on Cardiac amyloidosis medical therapy

Directions to Hospitals Treating Cardiac amyloidosis

Risk calculators and risk factors for Cardiac amyloidosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Supportive measures

Physical activity may continue as long as the patient can tolerate it.

Diet restrictions vary with the extent of cardiomyopathy and heart failure. These may include salt and/or fluid restrictions.

Pharmacotherapy

Diuretics (water pills) may be given to remove excess fluid.

Digoxin may be used cautiously to improve heart control in patients with atrial fibrillation.

Daily weight measurement may be recommended. A weight gain of 3 or 4 pounds or more over 1 or 2 days can indicate excessive fluid accumulation.

Some people benefit from chemotherapy or prednisone.

Pacemaker

A pacemaker may be needed if the conduction system is involved.

References


Template:WikiDoc Sources